Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
International Journal of Surgery Case Reports
|
October 27, 2018
Report of metastatic ileal neuroendocrine tumor to the submandibular gland
David Forner, Peter Cho, Martin Bullock, et al.
Clinical Breast Cancer
|
March 23, 2011
Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study
Daniel Rayson, Jennifer Isabelle Payne, Mohamed Abdolell, et al.
Therapeutic Advances in Medical Oncology
|
January 17, 2022
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
Christine Simmons, Daniel Rayson, Anil Abraham Joy, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2- Women with Metastatic Breast Cancer: Results from PALCAN Study
Daniel Rayson, Jonathan Bertin, Maxim Lemelin, et al.
Breast Cancer Research and Treatment
|
June 25, 2009
Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients
Orit Freedman, Eitan Amir, George Dranitsaris, et al.
Annals of Surgical Oncology
|
November 5, 2014
Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group
Simron Singh, Chris Dey, Hagen Kennecke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
Maureen E Trudeau, Mark J Clemons, Louise Provencher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2008
Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts
Roger von Moos, Beat J K Thuerlimann, Matti Aapro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors
Henry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Cancer Treatment Reviews
|
February 28, 2012
Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials
John R Mackey, Robert S Kerbel, Karen A Gelmon, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
International Journal of Surgery Case Reports
|
October 27, 2018
Report of metastatic ileal neuroendocrine tumor to the submandibular gland
David Forner, Peter Cho, Martin Bullock, et al.
Clinical Breast Cancer
|
March 23, 2011
Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study
Daniel Rayson, Jennifer Isabelle Payne, Mohamed Abdolell, et al.
Therapeutic Advances in Medical Oncology
|
January 17, 2022
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
Christine Simmons, Daniel Rayson, Anil Abraham Joy, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2- Women with Metastatic Breast Cancer: Results from PALCAN Study
Daniel Rayson, Jonathan Bertin, Maxim Lemelin, et al.
Breast Cancer Research and Treatment
|
June 25, 2009
Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients
Orit Freedman, Eitan Amir, George Dranitsaris, et al.
Annals of Surgical Oncology
|
November 5, 2014
Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group
Simron Singh, Chris Dey, Hagen Kennecke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
Maureen E Trudeau, Mark J Clemons, Louise Provencher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2008
Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts
Roger von Moos, Beat J K Thuerlimann, Matti Aapro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors
Henry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Cancer Treatment Reviews
|
February 28, 2012
Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials
John R Mackey, Robert S Kerbel, Karen A Gelmon, et al.
Page
of 9